Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insulin-sensitive Obesity: Prospective and Interventional Studies

NCT02017210 is registered in ClinicalTrials.gov with Garvan Institute of Medical Research as lead sponsor.

NCT NCT02017210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02017210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insulin-sensitive Obesity: Prospective and Interventional Studies
Lead sponsor
Garvan Institute of Medical Research
Phase
Observational
Overall status
Completed
Start date
November 30, 2013
Completion date
February 29, 2016
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin sensitivity/resistance, obesity